About the company AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare seg
A company profile report for AstraZeneca Pharma India Limited (AZPIL) from publisher Life Science Analytics Inc. is presented, with topics including management profile, company announcements, deals, alliances and product updates.EBSCO_bspAstrazeneca Pharma India Limited Medtrack Company Profile...
AstraZeneca Pharma India的现价与52周高点的百分比值是79.7%. 查看AstraZeneca Pharma India的现价与52周高点的百分比值趋势、图表等
AstraZeneca Pharma India于资产负债表中没有报告,截至九月 30, 2024止最近一个季度存在有意义的应付再保险费。 下表总结了AstraZeneca Pharma India过去五年的应付再保险费和百分比分析(common size): 财政年度应付再保险费资产资产占比 2020-03-31 NA 7.064 B 0.0% 2021-03-31 NA 7.747 B 0.0% 2022-03-31...
AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, announced that they have signed a memorandum of understanding with Docon Technologies, Bengaluru, for digitising 1,000 clinics across India.
AstraZeneca Pharma India Limited has received import and market permission in Form CT-20 from the Drugs Controller General of India for selumetinib 10 mg & 25 mg capsule. Selumetinib 10 mg & 25 mg capsule is indicated for treatment of paediatric patients 3 years of age and older with neurofib...
AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received extended indication approval from the Drugs Controller General of India (DGCI) for its drug, Dapagliflozin in the treatment of heart failure (HF) in adults. ...
Siva Padmanabhan, managing director, AstraZeneca India Private Limited, said, “The role of GCCs in the overall growth of the parent organisation is witnessing a shift. Over the last decade, GCCs in India are undertaking more strategic and transformative work critical to the success of the orga...
AstraZeneca Pharma India Ltd a leading biopharmaceutical company announces a change in its leadership with the appointment of Dr. Sanjeev Panchal as Country President & Managing Director, AstraZeneca Pharma India Ltd with effect from 1st January 2023. Sanjeev has been with AstraZeneca for 19 years ...
AstraZeneca India has launched 'Project Chariot' to help diagnose and treat patients with chronic lymphocytic leukemia (CLL) in India. It forms the first strategic partnership with Rajiv Gandhi Cancer Institute (RGCI) to help roll out the programme across North India and Delhi NCR region. ...